与长QT综合征相关的卡尔莫杜林变体破坏了缓慢激活的延迟整流器通道的活动
Liam McCormick1,2, Kirsty Wadmore1, Amy Milburn1
1Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
The Journal of physiology
|July 10, 2023
概括
卡尔莫杜林 (CaM) 的突变通过破坏其与Kv7.1通道的相互作用而导致长 QT 综合征 (LQTS),导致电流减少和心律延长. 这项研究揭示了CaM结构变化如何对LQTS产生影响.
科学领域:
- 分子心脏病学分子心脏病学
- 离子通道生理学 离子通道生理学
- 信号传递 信号传递
背景情况:
- 卡尔莫杜林 (CaM) 是一个关键的传感器,调节心脏离子通道,包括Kv7.1.1.
- 在CaM的突变与长QT综合征 (LQTS) 相关,这种疾病的特征是长时间的腹腔复极化和心律失常风险.
- Kv7.1通道功能障碍是先天性LQTS的主要原因,而CaM在其调制中的作用尚未完全理解.
研究的目的:
- 描述三种与LQTS相关的CaM变体 (D95V,N97I,D131H) 对Kv7.1通道功能的生物物理和调节作用.
- 阐明这些CaM突变对Kv7.1相互作用和缓慢延迟整流器电流 (IKs) 调节的结构和功能后果.
主要方法:
- 对CaM变种的生物物理特征.
- 对Kv7.1.1.对CaM变体结合亲和力的评估
- 在表达Kv7.1 (KCNQ1/KCNE1) 和CaM变异的HEK293T细胞中,补丁电生理学.
主要成果:
- 与野生类型的CaM相比,与LQTS相关的CaM变体表现出结构变化和对Kv7.1的结合亲和力降低.
- 这些CaM变体在生理系统度下显著降低了IKs电流密度.
- 这项研究表明,通过CaM变体对Kv7.1.1的调节受损的介导,具有直接的QT延长作用.
结论:
- 与LQTS相关的CaM突变扰乱了其结构,阻碍了Kv7.1复合体的形成,并减少了IKs.
- 这为如何改变CaM结构-功能关系对LQTS表型作出贡献提供了新的机械洞察力.
- 这些发现突出了CaM作为LQTS的潜在治疗点.
相关概念视频
Calmodulin-dependent Signaling
5.2K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.2K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.1K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.1K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
880
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
880
Antihypertensive Drugs: Action of Calcium Channel Blockers
579
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
579
Voltage-gated Ion Channels
8.3K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.3K
G-Protein Gated Ion Channels
4.6K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.6K


